NUCRYST Pharmaceuticals Corp. develops, manufactures and commercializes medical products that fight infection and inflammation. In addition, the Company’s nanocrystalline silver structures have exhibited potent anti-inflammatory properties in preclinical studies. It produces its nanocrystalline silver as a coating for wound dressing products under the trademark SILCRYST and as a powder for use in medical devices and as an active pharmaceutical ingredient (API). The Company is a majority owned subsidiary of The Westaim Corporation (Westaim).
(Source: 10-K)
